EUROPEAN ME ALLIANCE SURVEY AND REPORT a summary (part two)

Bonjour, 

Here's my second look and summary of the European ME Alliance survey and report on ME/CFS. It's a huge document and I can only read a little at a time. Plus I think that for those of you with this illness it's easier to understand in small amounts. 

First of all you can check out the first part here. 

You may also like to take a look at the interview done by David Tuller who interviewed the authors of the survey and report 

Symptoms and severity 

Severity 

The survey used a severity scale of the ICC (International Consensus Criteria) 

• mild (approx 50% reduction in pre-illness activity level) 
• moderate ( mostly housebound)
• severe ( mostly bedridden)
• very severe (totally bedridden and need help with basic functions) 

They also added two other categories 

• better than mild but not recovered 
• completely recovered 

The results were 

• 2.4% very severe 
• 16.0% severe 
• 53.8% moderate 
• 24% mild
• 3.7% better than mild 
• 0.2 % recovered 

It was also found that 

• more men than women had mild disease 
• more women than men had moderate disease 
• severe and very severe was a about the same for both 
• the young tend to have a more severe form of the disease
• early onset is a risk factor for severe disease

Symptom burden 

In the survey the respondents were asked which symptoms hindered them most in activities and daily living 

• the most restrictive was symptom exacerbation after exertion (PEM)
• sensitivity to light, sound and smell

Unfortunately cognitive problems (brain fog) was by mistake not included - probably because of brain fog! 

Fatigue that's mostly associated with ME/CFS was not rated as the most restrictive symptom regardless of severity. 

Comorbidities 

• 85% reported having at least one comorbidity 
• the most common being IBS, allergies and fibromyalgia
• plus postural orthostatic tachycardia syndrome (POTS)
• hypermobility or Ehler Danlos syndrome 
• hypermobile type (hEDS)
• thyroid problems 
• diabetes
• mast cell activation syndrome (MCAS) 
• 27% had one comorbidity 
• 25% had two 
• 48% had more than two 

Course of illness 

Little research has been done on prognosis of ME/CFS 

• 46% reported mainly deterioration
• 26% described a course of illness with initial fluctuations then deterioration
• 24% had experienced major fluctuations throughout the course of the illness
• 7% reported improvement 

• only 9% reported improvement during the previous year 
• 29% said they were stable during the previous year  
• 18% had experienced large fluctuations during the previous year 
• 44% reported deterioration in the last year 

Course of illness and disease duration

Among the respondents with a one year disease duration 37% reported experiencing large fluctuations. 

Large fluctuations decreased with disease duration - on average 17% with more than a 4 year disease duration 

Factors impacting the course of the illness 

• biological factors, like age of onset, gender and type of trigger
• how well the disease is accepted by family and friends 
• access to health care, social or financial benefits 
• management strategies 

I hope this format is easy to understand and follow. 

However, if you want to read the full document in your preferred language then follow the link here 

There's still more to come so look out for my next blog.

Au revoir

The French Femme 

xxx